Abstract
Most individual antipsychotics used in medium‐ and long‐term treatment of schizophrenia resulted in greater weight gain compared with placebo, a network meta‐analysis has found. Drugs that were associated with weight gain also tended to be associated with adverse outcomes in fasting glucose and lipid measures, the investigators reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
